Khosla Ventures

Khosla Ventures is a high-conviction, technology-first firm that backs non-consensus companies capable of reinventing large markets. It invests from Pre-Seed through Growth, but evaluates Seed and Main Fund opportunities differently: at Seed it prioritizes deep technical insight and cheap risk-reduction learning, while at later stages it expects more market proof, GTM clarity, and financial maturity.

Evaluation weights

How much weight this investor places on each dimension. Totals 100%.

Team-led · 33%

Metrics

Revenue, growth, and unit economics

Market

30%

Size, timing, and competitive landscape

Team

33%

Founder experience and execution ability

Product

30%

Differentiation and technical quality

Strong bias toward technical insight over polished storytelling
Prefers bold, non-consensus bets to incremental certainty
At Seed, prioritizes learning velocity and risk decomposition over spreadsheet precision
Will tolerate extreme technical risk if the upside and unfair advantage are extraordinary

Pitch difficulty

How hard it is to get a meeting and close funding from this investor.

Funded / yr

Deals closed in a typical year.

Led / yr

Rounds led in the last 12 months.

Pitches / yr

~3000

Decks reviewed in a typical year.

Acceptance rate

0.02%

Share of pitches that get funded.

Estimated — public data is not fully disclosed.

Why it's hard

Rejects me-too products and incumbent-copying strategies
Expects precise articulation of technical risks and cheap de-risking milestones
Targets billion-dollar outcomes with defensible unfair advantages
Maintains high founder and technical-insight standards across both Seed and Main funds

Khosla Ventures is highly selective because it seeks outlier companies with massive market potential, real technical differentiation, and founders capable of navigating unconventional, high-risk paths. Its willingness to fund very early does not make it easy to access; the bar for originality, technical clarity, and category-defining upside is unusually high.

Green flags

What drives a yes for this investor.

A bold, technically differentiated idea with a credible path to proving or disproving key assumptions quickly
Founders with exceptional technical depth, conviction, and the ability to attract outstanding talent
A very large market where success could produce a category-defining or billion-dollar outcome
Clear unfair advantage through IP, scientific breakthrough, business-model innovation, or proprietary access
A practical plan to decompose risk into milestones rather than relying on long-range storytelling

Red flags

What kills deals and gets a fast no.

Pitching an incremental clone of an existing winner
Using vanity metrics or long-term financial projections as the primary proof point
Failing to identify the core technical and market risks explicitly
Founders who want passive capital rather than active intellectual partnership
Unclear path to a very large market or no defensible moat if the product works

How to win

Patterns that lead to successful pitches.

Lead with the non-consensus insight and why now, not with generic market slides
Show a crisp risk-reduction plan: what are the key unknowns, how will you test them, and what will it cost
Demonstrate unfair advantage through science, IP, technical architecture, or novel business model
Present a founder-story that proves exceptional depth, conviction, and recruiting ability
For later stages, pair the technology thesis with credible GTM, revenue quality, and scaling discipline

Fund strategy & identity

Who they are and how they operate.

Use Seed fund to back 'crazy ideas' with plausible technical paths before consensus forms
Use Main fund to scale companies after key technical and market risks are partially retired
Invest across software, frontier tech, healthcare, fintech, and climate with a bias to disruptive platforms
Lead aggressively at Seed and selectively follow or co-lead larger rounds later
Favor startups with unfair advantages rooted in IP, science, novel business models, or unique partnerships

Firm identity

Aggressive techno-optimist Non-consensus, founder-backed risk taker Technology-first with strong science/deep-tech orientation Collaborative but intellectually demanding Global investor with a strong U.S. core

Investment focus

Industries, themes, and typical ARR expectations.

Industries

ConsumerEnterprise SoftwareFintechFrontier TechSpaceQuantumMedTech & DiagnosticsDigital HealthTherapeuticsSustainability & Climate

Investment themes

AI as a horizontal force across enterprise, healthcare, fintech, consumer, and industrial sectorsFrontier and deep tech including space, quantum, fusion, advanced materials, and hard tech systemsClimate and sustainability including food tech, batteries, energy, and decarbonization infrastructureDigital health, medtech, diagnostics, and therapeutics built on real scientific differentiationEnterprise software and developer platforms that create new system-of-work advantagesFintech and infrastructure models that use technology to reshape legacy market structure

Typical check by stage

Seed$1M-$5M

Series A$5M-$15M

Series B$10M-$30M

Series C$15M-$50M

Growth$30M-$100M

Typical ARR by stage

Pre Seed$0

Seed$0-$1M

Series A$1M-$5M

Series B$5M-$20M

Series C$20M+

Growth$20M+

Investment thesis

Core beliefs and strategy behind their investing approach.

KV’s investment thesis centers on technology‑driven disruption of large, addressable markets. The firm seeks “unfair advantages” such as proprietary IP, breakthrough science, novel business models, or unique partnerships, and prefers founders with deep technical expertise and conviction. Core sectors include Consumer, Enterprise, Fintech, Frontier (space, quantum, deep tech), MedTech & Diagnostics, Digital Health, Therapeutics, and Sustainability/Climate. AI is highlighted as a transformative force across all domains. Geography is global, with a strong U.S. base but investments in India, New Zealand, and other regions. KV targets early‑stage opportunities where a non‑consensus idea can become a category leader, backing both pure science experiments (Seed Fund) and later‑stage scaling (Main Fund). The firm avoids incremental “me‑too” products, business plans that depend on copying incumbents, and pitches that rely solely on long‑term financial projections without concrete technical risk mitigation. Its core belief is that ambitious, technically differentiated startups can reinvent societal goods and generate outsized value, and KV aims to be early, bold, and impactful by backing such “black‑swan” potential.

Decision patterns

How they evaluate and make investment decisions.

KV evaluates investments differently across its Seed and Main funds. For Seed, the firm looks for a “crazy idea” with a plausible technical path and a clear plan to reduce key risks cheaply. Weight is placed on (a) deep technical insight and risk decomposition, (b) founder quality and the ability to “engineer the gene pool,” and (c) a billion‑dollar market opportunity with a defensible unfair advantage (IP, business‑model innovation). They explicitly discount long‑range financial forecasts, vanity user metrics, and me‑too product copies. Deal‑breakers include lack of clear risk‑reduction milestones, teams seeking only capital without willingness to collaborate, and pitches that rely on copying incumbents. For the Main Fund, KV expects more risk to be retired, so market size, financials, go‑to‑market strategy, and team completeness gain weight, though technology risk remains significant. Traction is considered but is secondary at Seed. Overall, team‑tech insight and market potential dominate the decision matrix.

Risk appetite

KV exhibits a high‑conviction, aggressive risk posture. It is willing to lead or be the sole investor in seed rounds, embracing extreme technical uncertainty for ideas that challenge the status quo. The firm describes itself as an “aggressive techno‑optimist,” taking large risks to back “crazy ideas.” While the Main Fund participates in larger rounds (> $10 M) and can co‑lead, KV still prioritizes risk‑elimination learning over perfect financial forecasts. Evidence shows KV frequently leads seed investments (e.g., Redcar, Vertical Oceans, Formulary) and follows in later rounds (e.g., Siphox Health). This blend of lead‑seed aggression with selective follow‑on capacity reflects a willingness to back high‑variance opportunities while providing enough capital to scale once early risks are mitigated.

Notable investments

Key portfolio companies and why they fit the thesis.

Opendoor
Reinventing the inefficient real-estate market with a technology-driven operating model. Khosla invested in the 2014 Seed round.
FormularyLead
AI-based infrastructure for private-market fund administration. Khosla led the $4.6M seed (Jan 2026).
Peripheral LabsLead
Advanced sensing and vision tech for autonomous-grade sports experiences. Khosla led the $3.6M seed (Dec 2025).
Impossible Foods
Food-tech moonshot with massive environmental upside, consistent with KV's sustainability and deep-tech focus.
Guardant Health
Precision oncology liquid-biopsy platform that transforms healthcare diagnostics, a classic KV health-tech investment.
QuantumScape
Solid-state battery technology for EVs, representing KV's deep-tech energy-storage bet.
Nutanix
Category-creating enterprise infrastructure backed pre-revenue, illustrating KV's comfort with high technical risk before metrics appear.
Ultima Genomics
Platform that dramatically lowers genomics costs, fitting KV's deep-tech and large-impact healthcare thesis.

Key people

Partners who lead investments and shape the thesis.

VK
Vinod Khosla
Founder
Deep techAIEnergyHealthFood/sustainability
SK
Samir Kaul
Founding Partner & Managing Director
AIadvanced technologyhealthsustainabilityfood
SS
Sven Strohband
Managing Director
roboticsAIautonomynew industries
DW
David Weiden
Founding Partner & Managing Director
internet softwareservices
KR
Keith Rabois
Managing Director
operator-founder experienceinvests across sectors and stages

Public voice

Notable statements and public positions.

“We prefer brutal honesty to hypocritical politeness.” — KV homepage
“At the seed stage, we’re looking for a crazy idea … We don’t need to see a full team or even complete plans; we need to understand the key technology risks … and the economic and market benefits if it is successful.” — How We Decide page
“I am a technology possibilist, a techno‑optimist … there is need for regulation but no regulation before its time.” — Vinod Khosla, AI: Dystopia or Utopia blog post